Persistence and Long-Term Disease Control of Interleukin-17 Inhibitors and Interleukin-23 Inhibitors in Patients with Psoriasis: A Nationwide Cohort Study in Japan.

Saved in:
Bibliographic Details
Title: Persistence and Long-Term Disease Control of Interleukin-17 Inhibitors and Interleukin-23 Inhibitors in Patients with Psoriasis: A Nationwide Cohort Study in Japan.
Authors: Xu Y; Global Epidemiology, Johnson & Johnson, Beijing, People's Republic of China., Li T; Global Epidemiology, Johnson & Johnson, Beijing, People's Republic of China., Chang CL; Regional Medical Affairs Asia Pacific, Johnson & Johnson, Singapore, Singapore., Zhang Y; Global Epidemiology, Johnson & Johnson, Beijing, People's Republic of China., Masuda J; Medical Affairs, Janssen Pharmaceutical Companies of Johnson & Johnson, Tokyo, Japan., Wu GH; Global Epidemiology, Johnson & Johnson, Taipei, Taiwan., Wahking B; Regional Medical Affairs Asia Pacific, Johnson & Johnson, Singapore, Singapore., Imafuku S; Department of Dermatology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan., Qiu H; Global Epidemiology, Johnson & Johnson, Titusville, NJ, USA.
Source: Psoriasis (Auckland, N.Z.) [Psoriasis (Auckl)] 2026 Feb 11; Vol. 16, pp. 565823. Date of Electronic Publication: 2026 Feb 11 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101709086 Publication Model: eCollection Cited Medium: Internet ISSN: 2230-326X (Electronic) Linking ISSN: 2230326X NLM ISO Abbreviation: Psoriasis (Auckl) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2230-326X
DOI:10.2147/PTT.S565823